Publicacións en colaboración con investigadores/as de Karolinska Institute (22)

2024

  1. Progress on the development of Class A GPCR-biased ligands

    British Journal of Pharmacology

2022

  1. A 2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models

    Journal for ImmunoTherapy of Cancer, Vol. 10, Núm. 5

  2. Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination

    Immunity, Vol. 55, Núm. 9, pp. 1732-1746.e5

  3. NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals

    Molecular Medicine, Vol. 28, Núm. 1

  4. The Karolinska KI/K COVID-19 immune atlas: An open resource for immunological research and educational purposes

    Scandinavian Journal of Immunology, Vol. 96, Núm. 1

  5. Understanding the Role and Impact of Poly (Ethylene Glycol) (PEG) on Nanoparticle Formulation: Implications for COVID-19 Vaccines

    Frontiers in Bioengineering and Biotechnology, Vol. 10

2021

  1. In depth characterisation of the biomolecular coronas of polymer coated inorganic nanoparticles with differential centrifugal sedimentation

    Scientific Reports, Vol. 11, Núm. 1

  2. SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation

    Clinical and Translational Immunology, Vol. 10, Núm. 7

2020

  1. MAIT cell activation and dynamics associated with COVID-19 disease severity

    Science Immunology, Vol. 5, Núm. 51

  2. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

    Cell, Vol. 183, Núm. 1, pp. 158-168.e14

  3. TOX is expressed by exhausted and polyfunctional human effector memory CD8+ T cells

    Science Immunology, Vol. 5, Núm. 49

  4. The Identity of Human Tissue-Emigrant CD8+ T Cells

    Cell, Vol. 183, Núm. 7, pp. 1946-1961.e15

2019

  1. Tracking stem cells and macrophages with gold and iron oxide nanoparticles – The choice of the best suited particles

    Applied Materials Today, Vol. 15, pp. 267-279

2018

  1. How entanglement of different physicochemical properties complicates the prediction of in vitro and in vivo interactions of gold nanoparticles

    ACS Nano, Vol. 12, Núm. 10, pp. 10104-10113

2017

  1. Colloidal Gold Nanoparticles Induce Changes in Cellular and Subcellular Morphology

    ACS Nano, Vol. 11, Núm. 8, pp. 7807-7820

  2. Diverse Applications of Nanomedicine

    ACS Nano, Vol. 11, Núm. 3, pp. 2313-2381

  3. Influence of Size and Shape on the Anatomical Distribution of Endotoxin-Free Gold Nanoparticles

    ACS Nano, Vol. 11, Núm. 6, pp. 5519-5529

  4. Selected standard protocols for the synthesis, phase transfer, and characterization of inorganic colloidal nanoparticles

    Chemistry of Materials, Vol. 29, Núm. 1, pp. 399-461

2016

  1. In vivo degeneration and the fate of inorganic nanoparticles

    Chemical Society Reviews, Vol. 45, Núm. 9, pp. 2440-2457

  2. Labelling of mesenchymal stem cells with gold nano: An initial in vitro study towards future in vivo tracking of mesenchymal stem cells

    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY